Cambridge Investment Research Advisors’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Buy
776
+208
+37% +$172K ﹤0.01% 2617
2026
Q1
$415K Buy
568
+19
+3% +$14.9K ﹤0.01% 2978
2025
Q4
$462K Sell
549
-2,689
-83% -$2.3M ﹤0.01% 2803
2025
Q3
$2.39M Buy
3,238
+24
+0.7% +$15.8K 0.01% 1372
2025
Q2
$1.77M Buy
3,214
+2,229
+226% +$1.29M 0.01% 1518
2025
Q1
$583K Buy
+985
New +$622K ﹤0.01% 2284
2023
Q3
Sell
-725
Closed -$283K 3142
2023
Q2
$283K Buy
+725
New +$285K ﹤0.01% 2574

Other funds holding ARGX

Cambridge Investment Research Advisors's ARGX Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its argenx (ARGX) stake by 37% in Q2 2026, buying an estimated $172K and bringing the position to 776 shares worth $720K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Cambridge Investment Research Advisors first reported a position in ARGX in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.39M in Q3 2025. 505 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • Cambridge Investment Research Advisors held 776 shares of argenx worth $720K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 208 argenx shares in Q2 2026, an estimated $172K.
  • argenx made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2617 holding.
  • Cambridge Investment Research Advisors first reported a position in argenx in Q2 2023 and has held it in 7 quarters since.
  • Cambridge Investment Research Advisors's argenx position peaked at $2.39M in Q3 2025.
  • 505 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.